Martyn French
Martyn French
University of Western Australia; Royal Perth Hospital; University of Sheffield
Verified email at
TitleCited byYear
Immune restoration disease after antiretroviral therapy
MA French, P Price, SF Stone
Aids 18 (12), 1615-1627, 2004
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
G Meintjes, SD Lawn, F Scano, G Maartens, MA French, W Worodria, ...
The Lancet infectious diseases 8 (8), 516-523, 2008
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
P Price, C Witt, R Allock, D Sayer, M Garlepp, CC Kok, M French, S Mallal, ...
Immunological reviews 167 (1), 257-274, 1999
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy
MA French, N Lenzo, M John, SA Mallal, EJ McKinnon, IR James, P Price, ...
HIV medicine 1 (2), 107-115, 2000
Immune reconstitution inflammatory syndrome: a reappraisal
KH Mayer, MA French
Clinical Infectious Diseases 48 (1), 101-107, 2009
Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?
M John, J Flexman, MAH French
Aids 12 (17), 2289-2293, 1998
B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans
DT Avery, EK Deenick, CS Ma, S Suryani, N Simpson, GY Chew, ...
Journal of Experimental Medicine 207 (1), 155-171, 2010
Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death
DR Boulware, KH Hullsiek, CE Puronen, A Rupert, JV Baker, MA French, ...
Journal of Infectious Diseases 203 (11), 1637-1646, 2011
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions
LJ Haddow, R Colebunders, G Meintjes, SD Lawn, JH Elliott, YC Manabe, ...
The Lancet infectious diseases 10 (11), 791-802, 2010
Functional STAT3 deficiency compromises the generation of human T follicular helper cells
CS Ma, DT Avery, A Chan, M Batten, J Bustamante, S Boisson-Dupuis, ...
Blood, The Journal of the American Society of Hematology 119 (17), 3997-4008, 2012
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV …
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1145-1155, 2008
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study
A Carr, J Hudson, J Chuah, S Mallal, M Law, J Hoy, N Doong, M French, ...
Aids 15 (14), 1811-1822, 2001
Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and …
MA French, MS King, JM Tschampa, BA da Silva, AL Landay
The Journal of infectious diseases 200 (8), 1212-1215, 2009
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients.
MA French, SA Mallal, RL Dawkins
AIDS (London, England) 6 (11), 1293-1297, 1992
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor‐alpha
LJ Abraham, MAH French, RL Dawkins
Clinical & Experimental Immunology 92 (1), 14-18, 1993
Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases
P Price, G Morahan, D Huang, E Stone, KYM Cheong, A Castley, ...
Aids 16 (15), 2043-2047, 2002
Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
MA Jacobson, M French
AIDS (London, England) 12, S157-63, 1998
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
WM El-Sadr, B Grund, J Neuhaus, A Babiker, CJ Cohen, J Darbyshire, ...
Annals of internal medicine 149 (5), 289-99, 2008
Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy
P Price, N Mathiot, R Krueger, S Stone, NM Keane, MA French
Journal of Clinical Virology 22 (3), 279-287, 2001
The system can't perform the operation now. Try again later.
Articles 1–20